Candesartan Cilexetil and Hydrochlorothiazide
- Product NDC
- 70518-2720
- 11-digit product format
- 705182720
- Labeler code
- 70518
- Product ID
- 70518-2720_d6e70b03-c455-1fb3-e053-2995a90a62dd
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Candesartan Cilexetil and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA021093
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2020-05-01
- Marketing end
- 0000-00-00
- Substance
- CANDESARTAN CILEXETIL; HYDROCHLOROTHIAZIDE
- Active strength
- 32 mg/1; mg/1
- Pharmacologic classes
- Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2720-0 | 70518272000 | 90 TABLET in 1 BOTTLE, PLASTIC (70518-2720-0) | 90 tablet | 2020-05-01 | 0000-00-00 | No | No | Current |